While it it's too early to judge the success of Kaiser Permanente's Risant Health, the company's first two acquisitions show a commitment to adjoining organizations with a strong focus on population health — as well as a dedication to spreading Kaiser's value-based care delivery models across the country.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means. Learn More.
Rick Ratliff, a pharmacy industry veteran who was for a time CEO of Surescripts, built a national digital prescription network connecting doctors to pharmacies.
Alumis's lead drug candidate blocks TYK2, an inflammation target that's already addressed by Sotyktu, a Bristol Myers Squibb drug approved for plaque psoriasis. Alumis plans to begin two Phase 3 tests in this indication later this year.
In this month's episode, Senior Reporter Katie Adams explored some executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Rod Hochman, who is retiring from his role as CEO of Providence after a 45-year career in healthcare.
In this episode, we're joined by Randa Deaton, vice president of purchaser engagement at the Purchaser Business Group on Health. She talks about the organization's new Comprehensive Maternity Care Common Purchasing Agreement.
No comments